Company Filing History:
Years Active: 1992-2000
Title: Simon T. Hodgson: A Pioneer in Anti-Atherosclerotic Therapy
Introduction
Simon T. Hodgson, based in Beckenham, GB, is a distinguished inventor with a notable repertoire of 9 patents. His work has significantly impacted the field of medical therapy, particularly focusing on conditions related to atherosclerosis.
Latest Patents
Among his latest innovations is a patent concerning anti-atherosclerotic diaryl compounds. This invention is centered around diaryl compounds of formula (I) and explores their application in medical therapies aimed at prophylaxis and treatment for conditions requiring an ACAT inhibitor, such as hyperlipidaemia and atherosclerosis. The patent also addresses pharmaceutical compositions and the processes necessary for preparing these compounds, contributing valuable knowledge to the medical community.
Career Highlights
Throughout his career, Simon Hodgson has been associated with prominent companies in the pharmaceutical industry, including Glaxo Wellcome Inc. and Burroughs Wellcome Co. His expertise and contributions have positioned him as a significant figure in the innovation and development of medical therapies.
Collaborations
Hodgson has collaborated with esteemed colleagues, including Robin H. Nicol and Martin J. Slater. These partnerships have facilitated the advancement of his research and the development of innovative therapeutic solutions.
Conclusion
Simon T. Hodgson's dedication to pioneering medical solutions has led to several impactful patents, particularly in the area of atherosclerosis treatment. His collaborations and career achievements highlight his role as a vital contributor to the realm of medical innovations.